Amazing sessin is ongoing, just started with an excellent wrap up the recent year updates by @BiykemB and Jun-ichi Noiri, MD presented MYSTICS score for SCD risk in Sarcoidosis patients, which is well calibrated and has high discriminative ability with lower NNT for ICD. #ACC26
All you need to know about the latest hot science in #HeartFailure is brought to you by @lamcardio and @MarcoMetra, and moderated by @leventpy👇
DAPA ACT HF-TIMI 68: Dapagliflozin in Patients Hospitalised for Acute Heart Failure
VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure
VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure and VICTORIA: Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction
ODYSSEY-HCM: Mavacamten in nHCM
MAPLE-HCM: aficamten vs metoprolol in oHCM
#ESCCongress #ESCsnacks
Just saying ‘severe TR’ is not enough — defining the mechanism (primary vs secondary) is crucial as it guides therapy. 🫀 3D assessment of the tricuspid annulus is recommended, since severe annular dilation is the leading cause of TTVR failure.#esc2025#EACVI@denisamuraru
CV imaging in elder poses unique challenges: contrast safety, patient cooperation, and cognitive decline. Recent Diast Dysfxn guideline emphasize that structural changes due to aging are not just ‘normal’ but integral to cardiac remodeling #ESC2025@NAjmoneMarsan@EACVIPresident
The 10 key points of the 2025 ESC guidelines on myocarditis and pericarditis presented today and just published on the EHJ: Eur Heart J. 2025 Aug 29:ehaf192. doi: 10.1093/eurheartj/ehaf192.
Started the day with a DH &AI session on top cutting age digital devices to watch ..Great presentation from Prof Mac Rae on wearables and burning questions from prof Barbara Casadei ⭐️
#ESCCongress